acyclovir NDC 68462-746

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-746Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0746Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-746-17	68462074617	1 TUBE in 1 CARTON (68462-746-17) / 15 g in 1 TUBEMarketed from Jul 31, 2017
68462-746-35	68462074635	1 TUBE in 1 CARTON (68462-746-35) / 30 g in 1 TUBEMarketed from Jul 31, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): acyclovir
Generic name (nonproprietary): acyclovir
Active ingredients: Acyclovir — 50 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205510
Marketing start: Jul 31, 2017
Listing expires: Dec 31, 2027
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 68462-746_091cd2ff-6773-415a-9529-4f8386512c41SPL ID 091cd2ff-6773-415a-9529-4f8386512c41SPL set ID 149f4418-7668-4d34-a6f9-69bf3a9c5049RxCUI 197312UNII X4HES1O11FUPC 0368462746356
Pharmacologic class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462074617 followed by a unit qualifier and the quantity

Package 68462-0746-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous Herpes simplex virus infections in immunocompromised patients.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205510

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205510
Product	Strength	Form · route	Labeler	Product NDC
acyclovir	Acyclovir 50 mg/g	OintmentTopical	NuCare Pharmaceuticals, Inc.	68071-3909
acyclovir	Acyclovir 50 mg/g	OintmentTopical	Northstar Rx LLC	16714-885
acyclovir	Acyclovir 50 mg/g	OintmentTopical	A-S Medication Solutions	50090-6561